Biotech | February 28, 2026
Synthekine teams up with Merck to test breakthrough lung cancer combo
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
Arcellx develops innovative immunotherapies for cancer and other incurable diseases
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
The Phase 2 trial, conducted through Starton’s Sargon Site Network, is expanding from two to six sites across the U.S.
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
Subscribe To Our Newsletter & Stay Updated
